Chairpersons: M. Böhm (Homburg/Saar), R. Ferrari (Ferrara, IT)
(zHS587) | Drugs, cells or devices in prevention of LV remodeling |
|
G. Ertl (Würzburg) |
(zHS588) | Influence of comorbidities on outcome |
|
D. J. van Veldhuisen (Groningen, NL) |
(zHS589) | RAS inhibitors, ß-blockers, aldosteron antagonists: All class effects? |
|
E. Erdmann (Köln) |
(zHS590) | Problems in implementation of guidelines |
|
P. Ponikowski (Wroclaw, PL) |